| CXSB1900013 | 注射用卡瑞利珠单抗 | camrelizumab | Lyophilized | Biological Products | Supplementary Application | 2019-06-21 | 苏州盛迪亚生物医药有限公司 | Suzhou Suncadia Biopharmaceuticals Co Ltd | Certificate Issued | 2019-07-08 | view |
| CXSB1900021 | 注射用卡瑞利珠单抗 | camrelizumab | Lyophilized | Biological Products | Supplementary Application | 2019-09-12 | 苏州盛迪亚生物医药有限公司 | Suzhou Suncadia Biopharmaceuticals Co Ltd | Certificate Issued | 2019-11-28 | view |
| CXSB2000002 | 注射用卡瑞利珠单抗 | camrelizumab | Lyophilized | Biological Products | Supplementary Application | 2020-01-17 | 苏州盛迪亚生物医药有限公司 | Suzhou Suncadia Biopharmaceuticals Co Ltd | In Review | 2020-01-16 | view |
| CXSB2000025 | 注射用卡瑞利珠单抗 | camrelizumab | Lyophilized | Biological Products | Supplementary Application | 2020-07-04 | 苏州盛迪亚生物医药有限公司 | Suzhou Suncadia Biopharmaceuticals Co Ltd | Certificate Issued | 2020-10-27 | view |
| CXSB2000173 | 注射用卡瑞利珠单抗 | camrelizumab | Lyophilized | Biological Products(1) | Supplementary Application | 2021-01-05 | 苏州盛迪亚生物医药有限公司 | Suzhou Suncadia Biopharmaceuticals Co Ltd | In Review | 2021-01-04 | view |
| CXSB2100017 | 注射用卡瑞利珠单抗 | camrelizumab | Lyophilized | Biological Products | Supplementary Application | 2021-03-12 | 苏州盛迪亚生物医药有限公司 | Suzhou Suncadia Biopharmaceuticals Co Ltd | In Review | 2021-03-11 | view |
| CXSB2101020 | 注射用卡瑞利珠单抗 | camrelizumab | Lyophilized | Biological Products | Supplementary Application | 2021-06-22 | | Suzhou Suncadia Biopharmaceuticals Co Ltd | | | view |
| CXSB2101023 | 注射用卡瑞利珠单抗 | camrelizumab | Lyophilized | Biological Products(1) | Supplementary Application | 2021-06-25 | | Suzhou Suncadia Biopharmaceuticals Co Ltd | | | view |
| CXSB2101024 | 注射用卡瑞利珠单抗 | camrelizumab | Lyophilized | Biological Products | Supplementary Application | 2021-07-08 | | Suzhou Suncadia Biopharmaceuticals Co Ltd | | | view |
| CXSB2200037 | 注射用卡瑞利珠单抗 | camrelizumab | Lyophilized | Biological Products(1) | Supplementary Application | 2022-04-21 | | Suzhou Suncadia Biopharmaceuticals Co Ltd | | | view |
| CXSB2200095 | 注射用卡瑞利珠单抗 | camrelizumab | Lyophilized | Biological Products | Supplementary Application | 2022-11-05 | | Suzhou Suncadia Biopharmaceuticals Co Ltd | | | view |
| CXSB2200103 | 注射用卡瑞利珠单抗 | camrelizumab | Lyophilized | Biological Products | Supplementary Application | 2022-12-08 | | Suzhou Suncadia Biopharmaceuticals Co Ltd | | | view |
| CXSB2300055 | 注射用卡瑞利珠单抗 | camrelizumab | Lyophilized | Biological Products(1) | Supplementary Application | 2023-05-23 | | Suzhou Suncadia Biopharmaceuticals Co Ltd | | | view |
| CXSB2400005 | 注射用卡瑞利珠单抗 | camrelizumab | Lyophilized | Biological Products | Supplementary Application | 2024-01-13 | | Suzhou Suncadia Biopharmaceuticals Co Ltd | | | view |
| CXSL1400153 | 注射用SHR-1210 | camrelizumab | Lyophilized | Biological Products(1) | New Drug Application | 2015-01-19 | 上海恒瑞医药有限公司 | Shanghai Hengrui Pharmaceutical Co Ltd | Certificate Issued | 2016-02-04 | view |
| CXSL1900009 | 注射用卡瑞利珠单抗 | camrelizumab | Lyophilized | Biological Products(1) | New Drug Application | 2019-02-03 | 苏州盛迪亚生物医药有限公司 | Suzhou Suncadia Biopharmaceuticals Co Ltd | In Review | 2019-02-02 | view |
| CXSL1900030 | 注射用卡瑞利珠单抗 | camrelizumab | Lyophilized | Biological Products(1) | New Drug Application | 2019-03-26 | 苏州盛迪亚生物医药有限公司 | Suzhou Suncadia Biopharmaceuticals Co Ltd | In Review | 2019-03-25 | view |
| CXSL1900036 | 注射用卡瑞利珠单抗 | camrelizumab | Lyophilized | Biological Products(1) | New Drug Application | 2019-04-24 | 苏州盛迪亚生物医药有限公司 | Suzhou Suncadia Biopharmaceuticals Co Ltd | In Review | 2019-04-22 | view |
| CXSL1900037 | 注射用卡瑞利珠单抗 | camrelizumab | Lyophilized | Biological Products(1) | New Drug Application | 2019-04-24 | 苏州盛迪亚生物医药有限公司 | Suzhou Suncadia Biopharmaceuticals Co Ltd | In Review | 2019-04-22 | view |
| CXSL1900054 | 注射用卡瑞利珠单抗 | camrelizumab | Lyophilized | Biological Products(1) | New Drug Application | 2019-06-21 | 苏州盛迪亚生物医药有限公司 | Suzhou Suncadia Biopharmaceuticals Co Ltd | In Review | 2019-06-20 | view |
